ACM
DGX icon

Advisors Capital Management’s Quest Diagnostics DGX Stock Holding History

Advisors Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.4M Buy
327,575
+324
+0.1% +$63.6K 0.74% 36
2026
Q1 		$64.1M Buy
327,251
+13,413
+4% +$2.61M 0.75% 40
2025
Q4 		$54.5M Buy
313,838
+16,194
+5% +$2.95M 0.64% 44
2025
Q3 		$56.7M Buy
297,644
+14,258
+5% +$2.53M 0.7% 42
2025
Q2 		$50.9M Buy
283,386
+32,131
+13% +$5.58M 0.7% 43
2025
Q1 		$42.5M Buy
251,255
+6,771
+3% +$1.11M 0.66% 47
2024
Q4 		$36.9M Buy
244,484
+6,326
+3% +$984K 0.58% 50
2024
Q3 		$37M Buy
238,158
+7,463
+3% +$1.11M 0.6% 51
2024
Q2 		$31.6M Buy
230,695
+11,555
+5% +$1.58M 0.55% 57
2024
Q1 		$29.2M Sell
219,140
-8,150
-4% -$1.06M 0.53% 58
2023
Q4 		$31.3M Buy
227,290
+183,619
+420% +$24.1M 0.64% 46
2023
Q3 		$5.32M Sell
43,671
-14,505
-25% -$1.93M 0.14% 149
2023
Q2 		$8.18M Buy
58,176
+1,968
+4% +$271K 0.2% 129
2023
Q1 		$7.95M Sell
56,208
-1,510
-3% -$216K 0.21% 123
2022
Q4 		$9.03M Sell
57,718
-1,140
-2% -$164K 0.25% 113
2022
Q3 		$8.85M Sell
58,858
-1,046
-2% -$138K 0.24% 116
2022
Q2 		$7.97M Buy
59,904
+619
+1% +$84.3K 0.24% 111
2022
Q1 		$8.11M Buy
59,285
+287
+0.5% +$40K 0.22% 110
2021
Q4 		$10.2M Buy
58,998
+805
+1% +$122K 0.28% 102
2021
Q3 		$8.46M Buy
58,193
+2,678
+5% +$392K 0.26% 109
2021
Q2 		$7.33M Buy
55,515
+418
+0.8% +$54.7K 0.23% 120
2021
Q1 		$7.07M Buy
55,097
+8,720
+19% +$1.07M 0.25% 113
2020
Q4 		$5.53M Buy
46,377
+256
+0.6% +$31.2K 0.21% 127
2020
Q3 		$5.28M Buy
46,121
+127
+0.3% +$15K 0.25% 112
2020
Q2 		$5.24M Buy
45,994
+2,537
+6% +$269K 0.26% 106
2020
Q1 		$3.49M Buy
43,457
+2,391
+6% +$248K 0.22% 97
2019
Q4 		$4.38M Buy
41,066
+653
+2% +$68.1K 0.2% 111
2019
Q3 		$4.33M Buy
40,413
+678
+2% +$69.6K 0.24% 103
2019
Q2 		$4.04M Buy
39,735
+3,074
+8% +$295K 0.24% 109
2019
Q1 		$3.31M Buy
36,661
+10,383
+40% +$900K 0.21% 119
2018
Q4 		$2.19M Sell
26,278
-1,171
-4% -$110K 0.16% 148
2018
Q3 		$2.96M Buy
27,449
+1,936
+8% +$212K 0.19% 133
2018
Q2 		$2.81M Buy
25,513
+1,325
+5% +$138K 0.19% 133
2018
Q1 		$2.43M Buy
24,188
+2,345
+11% +$240K 0.18% 134
2017
Q4 		$2.15M Buy
21,843
+2,487
+13% +$236K 0.17% 136
2017
Q3 		$1.81M Buy
19,356
+1,752
+10% +$186K 0.15% 148
2017
Q2 		$1.96M Buy
17,604
+883
+5% +$93.4K 0.16% 142
2017
Q1 		$1.64M Buy
+16,721
New +$1.59M 0.14% 145
2015
Q2 		– Sell
-25,159
Closed -$1.93M – 161
2015
Q1 		$1.93M Buy
25,159
+1,106
+5% +$79.2K 0.22% 118
2014
Q4 		$1.61M Sell
24,053
-19
-0.1% -$1.2K 0.2% 117
2014
Q3 		$1.46M Sell
24,072
-11,795
-33% -$727K 0.19% 124
2014
Q2 		$2.1M Buy
35,867
+1,825
+5% +$107K 0.28% 102
2014
Q1 		$1.97M Buy
34,042
+11,255
+49% +$603K 0.3% 96
2013
Q4 		$1.22M Buy
22,787
+2,573
+13% +$153K 0.21% 124
2013
Q3 		$1.25M Buy
20,214
+2,009
+11% +$120K 0.26% 103
2013
Q2 		$1.1M Buy
+18,205
New +$1.08M 0.25% 103

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Advisors Capital Management's DGX Position: Q2 2026 in Review

Advisors Capital Management increased its Quest Diagnostics (DGX) stake by 0.1% in Q2 2026, buying an estimated $63.6K and bringing the position to 327,575 shares worth $69.4M. The position accounts for 0.74% of the portfolio, ranked #36.

Advisors Capital Management first reported a position in DGX in Q2 2013 and has held it in 46 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Advisors Capital Management held 327,575 shares of Quest Diagnostics worth $69.4M as of Q2 2026.
  • Advisors Capital Management bought 324 Quest Diagnostics shares in Q2 2026, an estimated $63.6K.
  • Quest Diagnostics made up 0.74% of Advisors Capital Management's portfolio in Q2 2026, its #36 holding.
  • Advisors Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 46 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.